The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization

Glucocorticoids (GCs) exert profound effects on bone and are essential for human osteoblast differentiation. However, GCs are still interpreted as negative regulators of bone formation, mainly caused by the detrimental effects on bone after clinical use of GCs. In this paper we emphasize the importance of GCs for proper human osteoblast differentiation and matrix mineralization. We show that human osteoblast differentiation needs to be triggered by GCs in a specific time-window during the early stages of development. Exposure to GCs in the beginning of osteoblast development induces a dose dependent increase in alkaline phosphatase activity and matrix mineralization. GC-induced differentiation stimulated expression of genes involved in bone formation and suppressed genes that negatively regulate bone formation and mineralization. Furthermore we highlight the importance of local cortisol activation in osteoblasts by expression of 11beta-hydroxysteroid dehydrogenase 1 (11beta-HSD1).

[1]  G. Coetzee,et al.  Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle , 2000, The Journal of Biological Chemistry.

[2]  G. Stein,et al.  Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: interrelationship of morphology and gene expression by in situ hybridization. , 1995, Experimental cell research.

[3]  P. Hulley,et al.  Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. , 2003, Endocrinology.

[4]  G. Reilly,et al.  BMP Responsiveness in Human Mesenchymal Stem Cells , 2003, Connective tissue research.

[5]  E. Vuorio,et al.  Characterization of the murine Timp4 gene, localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA. , 2002, Biochimica et biophysica acta.

[6]  M. Mori,et al.  Establishment and Characterization of a Simian Virus 40‐Immortalized Osteoblastic Cell Line from Normal Human Bone , 1993, Japanese journal of cancer research : Gann.

[7]  P. Hauschka,et al.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. , 1996, The Biochemical journal.

[8]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[9]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Daniel Chappard,et al.  Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: Effects of dexamethasone and calcitriol , 2003, Journal of cellular biochemistry.

[11]  R. Eastell,et al.  Glucocorticoid-induced osteoporosis. , 2001, Current opinion in rheumatology.

[12]  Su‐Li Cheng,et al.  Expression of bone matrix proteins during dexamethasone‐induced mineralization of human bone marrow stromal cells , 1996, Journal of cellular biochemistry.

[13]  M. Selman,et al.  MMP-1: the elder of the family. , 2005, The international journal of biochemistry & cell biology.

[14]  L. Song.  Effects of retinoic acid and dexamethasone on proliferation, differentiation, and glucocorticoid receptor expression in cultured human osteosarcoma cells. , 1994, Oncology research.

[15]  Allan Bradley,et al.  Increased bone formation in osteocalcin-deficient mice , 1996, Nature.

[16]  M. Andreeff,et al.  Cell Proliferation and Differentiation , 2003 .

[17]  H. Pols,et al.  Estradiol formation by human osteoblasts via multiple pathways: Relation with osteoblast function , 1999, Journal of cellular biochemistry.

[18]  G. Stein,et al.  Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter. , 1993, Biochemistry.

[19]  E. Canalis,et al.  11β‐Hydroxysteroid Dehydrogenase, an Amplifier of Glucocorticoid Action in Osteoblasts , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  J. Aubin,et al.  Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. , 1987, Endocrinology.

[21]  E. Canalis,et al.  Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. , 2001, Bone.

[22]  A. Uitterlinden,et al.  11β-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation , 2005 .

[23]  H. Weinans,et al.  Stretch‐induced phosphorylation of ERK1/2 depends on differentiation stage of osteoblasts , 2004, Journal of cellular biochemistry.

[24]  B. Riggs,et al.  Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. , 1993, Endocrinology.

[25]  F. Glorieux,et al.  Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture , 1983, The Journal of cell biology.

[26]  Y. Amagai,et al.  In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.

[27]  B. Peterkofsky,et al.  Species differences in cis‐elements of the Proα1(I) procollagen promoter and their binding proteins , 1999, Journal of cellular biochemistry.

[28]  M. Cooper,et al.  Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. , 2000, Bone.

[29]  G. Hunter,et al.  Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. , 1994, The Biochemical journal.

[30]  J. Heersche,et al.  Glucocorticoid‐Induced Osteoporosis: Both In Vivo and In Vitro Concentrations of Glucocorticoids Higher Than Physiological Levels Attenuate Osteoblast Differentiation , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  J. Shine,et al.  1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. , 1989, Science.

[32]  E. Canalis,et al.  Mechanisms of Glucocorticoid Action in Bone , 2002, Current osteoporosis reports.

[33]  M. Hewison,et al.  Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. , 1999, The Journal of endocrinology.

[34]  A. Boskey,et al.  Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. , 1993, Bone and mineral.

[35]  M. Takagi,et al.  Inductive Effects of Dexamethasone on the Gene Expression of Cbfa1, Osterix and Bone Matrix Proteins During Differentiation of Cultured Primary Rat Osteoblasts , 2004, Journal of Molecular Histology.

[36]  A. Boskey,et al.  Osteopontin Deficiency Increases Mineral Content and Mineral Crystallinity in Mouse Bone , 2002, Calcified Tissue International.

[37]  S. Shapiro,et al.  Matrix metalloproteinase degradation of extracellular matrix: biological consequences. , 1998, Current opinion in cell biology.

[38]  A. Boskey,et al.  Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. , 1998, Bone.

[39]  C. Maniatopoulos,et al.  Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats , 1988, Cell and Tissue Research.

[40]  C. Schneeberger,et al.  Production and actions of estrogens. , 2002, The New England journal of medicine.

[41]  J. Aubin,et al.  Dexamethasone alters the subpopulation make‐up of rat bone marrow stromal cell cultures , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  M. Cooper,et al.  Glucocorticoid activity, inactivity and the osteoblast. , 1999, The Journal of endocrinology.

[43]  M. Mori,et al.  Glucocorticoids induce mineralization coupled with bone protein expression without influence on growth of a human osteoblastic cell line. , 1995, Cell structure and function.

[44]  H. Schweikert,et al.  Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1 alpha,25-dihydroxycholecalciferol receptors. , 1994, Journal of andrology.

[45]  Theresa L Chen,et al.  Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. , 2004, Bone.

[46]  N. Athanasou,et al.  Effect of corticosteroids on human osteoclast formation and activity. , 2002, The Journal of endocrinology.

[47]  R. Weinstein.  Glucocorticoid-Induced Osteoporosis , 2004, Reviews in Endocrine and Metabolic Disorders.

[48]  E. Canalis.  Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. , 1996, The Journal of clinical endocrinology and metabolism.

[49]  K. Cutroneo,et al.  Identification of a glucocorticoid response element in the human transforming growth factor beta 1 gene promoter. , 1998, The international journal of biochemistry & cell biology.

[50]  N. Jørgensen,et al.  Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts , 2004, Steroids.